Article
Evaluation of MAOA Gene Polymorphism on the Efficacy of Antidepressant Treatment and Craving Severity for Betel-Quid Use Disorder
2024-08-02
Abstract excerpt
Betel quid (BQ) use disorder (BUD) is prevalent in many Asian countries, impacting approximately 600 million people. We conducted a randomized clinical trial to analyze the impact of MAOA genetic variations on the severity of BQ craving. This was measured using DSM-5 criteria and Yale-Brown Obsessive Compulsive Scale modified for betel-quid (Y-BOCS-BQ). Participants were grouped according to the severity of BUD an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- df86d6c0-947f-5298-ba5e-5cb9de15d6b8
- DOI
- 10.20944/preprints202408.0036.v1
